Clinical trials in Harderwijk – page 3

Multiple innovative trials focusing on non-small cell lung cancer (NSCLC) treatments, evaluating new therapeutic combinations and targeted approaches for different disease stages.

• Advanced and Metastatic NSCLC
• Early-Stage Treatment
• Targeted Therapies

Studies are investigating novel drug combinations and immunotherapy approaches to improve patient outcomes.

Groundbreaking research in chronic lymphocytic leukemia (CLL) and lymphomas, exploring various treatment combinations and duration-optimized approaches.

• First-line CLL Treatments
• Novel Drug Combinations
• Treatment Duration Studies

Focus on personalized treatment strategies and improved patient outcomes through innovative therapies.

Studies addressing atherosclerotic cardiovascular disease and heart failure prevention, testing new therapeutic approaches and preventive strategies.

• Heart Failure Prevention
• Cardiovascular Risk Management
• Novel Therapeutic Agents

Emphasis on reducing major adverse cardiovascular events and improving patient outcomes.